Rapid and reliable inactivation protocols for the diagnostics of emerging viruses: The example of SARS‐CoV‐2 and monkeypox virus-Reference-Cited by-同舟云学术

Rapid and reliable inactivation protocols for the diagnostics of emerging viruses: The example of SARS‐CoV‐2 and monkeypox virus

Published:2022-09-21 Issue:1 Volume:95 Page:
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:Journal of Medical Virology

Author:

Quéromès Grégory¹^ORCID,Frobert Emilie¹²,Bouscambert‐Duchamp Maude²,Oblette Antoine²,Valette Martine¹²³,Billaud Geneviève²,Escuret Vanessa¹²³,Lina Bruno¹²³,Morfin Florence¹²,Gaymard Alexandre¹²

Affiliation:

1. Centre International de Recherche en Infectiologie (CIRI), Team VirPatH, Université de Lyon, Inserm, U1111, CNRS, UMR5308, ENS de Lyon Université Claude Bernard Lyon 1 Lyon France

2. Laboratoire de Virologie Institut des Agents Infectieux, Hospices Civils de Lyon Lyon France

3. Centre National de Référence des Virus des infections respiratoires (dont la grippe) Hospices Civils de Lyon Lyon France

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.28126

Reference20 articles.

1. World Health Organization. Multi‐country outbreak of monkeypox external situation report #2—July 25 2022.2022.

2. Centers for Disease Control and Prevention. Monkeypox outbreak global map. 2022. Accessed July 28 2022. https://www.cdc.gov/poxvirus/monkeypox/response/2022/world-map.html

3. Determination of 50% endpoint titer using a simple formula

4. Association Française de Normalisation.NF EN 14476+A2-Antiseptiques et désinfectants chimiques — Essai quantitatif de suspension pour l'évaluation de l'activité virucide dans le domaine médical — Méthode d'essai et prescriptions(Phase 2/Étape 1). AFNOR Editions;2019.https://viewerbdc.afnor.org/html/display/T9-40j9fF341

5. World Health Organization. WHO guidelines on viral inactivation and removal procedures intended to assure the viral safety of human blood plasma products; 2004.https://www.who.int/publications/m/item/WHO-TRS924-Annex4

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current status of pathogen handling in European laboratories: focus on viral inactivation process;Frontiers in Bioengineering and Biotechnology;2024-06-07

2. Preparing for another Ebola Outbreak: The impact of viral inactivation methods on commonly measured biochemistry analytes in plasma and urine;Clinical Biochemistry;2024-02

3. Evaluation of Stability, Inactivation, and Disinfection Effectiveness of Mpox Virus;Viruses;2024-01-11

4. Review of virological methods for laboratory diagnosis and characterization of monkeypox virus (MPXV): lessons learned from the 2022 Mpox outbreak;Acta Dermatovenerologica Alpina Pannonica et Adriatica;2024

5. Heat inactivation does not alter host plasma cell-free DNA characteristics in infectious disease research;Clinica Chimica Acta;2024-01